IP Library Granted Patent US 10,117,928
Granted Patent B2
US 10,117,928 · App. 15/390,948 · Granted Nov 6, 2018

Annexin II compositions

Inventors: John R. Ohlfest (Minneapolis, MN); Michael R. Olin (New Brighton, MN)
Assignee: REGENTS OF THE UNIVERSITY OF MINNESOTA
A61K39/39A61K38/16A61K38/1709A61K39/0011A61K51/087C07K14/00A61K2039/55516
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,117,928
App. No.
15/390,948
Granted
Nov 6, 2018
Kind
B2
Abstract

The present invention provides compositions and methods that involve the 36 kDa annexin II monomer, which has been identified as having immunostimulatory properties. Accordingly, in one aspect, the invention provides compositions that include at least one 36 kDa annexin II monomer or an immunomodulatory fragment thereof. In another aspect, the invention provides methods that include administering to a subject a composition that includes at least one 36 kDa annexin II monomer or an immunomodulatory fragment thereof. In another aspect, the invention provides methods that induce an in situ increase in the 36 kDa annexin II monomer by administering to a subject an amount of composition effective to induce localized hypoxia sufficient to cause a localized increase in annexin II.

Claims (16)

1. A composition comprising:

a fragment of the 36 kDa annexin II monomer, wherein the fragment comprises amino acids 2-36 of SEQ ID NO:7;

at least one antigen; and

an adjuvant coupled to the annexin II monomer fragment.

2. A composition comprising:

a fragment of the 36 kDa annexin II monomer, wherein the fragment comprises amino acids 2-36 of SEQ ID NO:7;

at least one antigen; and

a targeting moiety coupled to the annexin II monomer fragment.

3. The composition of claim 2 wherein the coupling comprises a covalent bond between the annexin II monomer fragment and the targeting moiety.

4. The composition of claim 2 wherein the coupling comprises a polypeptide fusion between the annexin II monomer fragment and the targeting moiety.

5. A composition comprising:

a fragment of the 36 kDa annexin II monomer, wherein the fragment comprises amino acids 2-36 of SEQ ID NO:7;

at least one antigen; and

a stabilizing moiety coupled to the annexin II monomer fragment.

6. The composition of claim 5 wherein the coupling comprises a covalent bond between the annexin II monomer fragment and the stabilizing moiety.

7. The composition of claim 5 wherein the coupling comprises a polypeptide fusion between the annexin II monomer fragment and the stabilizing moiety.

Assignments (2)
CONFIRMATORY LICENSE Recorded Feb 13, 2017
From: UNIVERSITY OF MINNESOTA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 041690/0168 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2017
From: OHLFEST, JOHN R.; OLIN, MICHAEL R.
To: REGENTS OF THE UNIVERSITY OF MINNESOTA
Reel/Frame 040987/0056 →
Continuity (4)
Continuation 13878023
Provisional Application 61391316 · Oct 8, 2010
Provisional Application 61437873 · Jan 31, 2011
Related Publication 20170128570A1 · May 11, 2017